Scientific and medical advances weren’t the only topic of discussion at the 51st American Society of Hematology Annual Meeting that began over the weekend in New Orleans, LA, as merger and acquisition activity took center stage. Early this morning, Celgene Corporation (CELG) announced the acquisition of privately-held Gloucester Pharmaceuticals for $340 million in...
Read More »